SCHEMBL15901896

SCHEMBL15901896

COc1cc(NC(=O)c2ccc(Br)cc2F)ccn1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SORT1 Q99523 3/20 0.57
ALDH1A1 P00352 4/20 0.54
SMN1; SMN2 Q16637 3/20 0.54
KMT2A Q03164 3/20 0.54
LMNA P02545 2/20 0.54
GAA P10253 2/20 0.54
NPC1 O15118 2/20 0.54
RAB9A P51151 2/20 0.54
STAT3 P40763 1/20 0.49
CYP1A2 P05177 2/20 0.49
CYP2C9 P11712 2/20 0.49
CYP2C19 P33261 2/20 0.49
MAPT P10636 3/20 0.46
HSD17B10 Q99714 2/20 0.46
GFER P55789 1/20 0.46
GPR27 Q9NS67 1/20 0.46
SCN10A Q9Y5Y9 2/20 0.46
KCNK3 O14649 1/20 0.46
KCNK9 Q9NPC2 1/20 0.46
HDAC4 P56524 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15901905 0.85 SORT1 (0.57) SORT1ALDH1A1SMN1; SMN2KMT2ALMNA
SCHEMBL28921272 0.83 SORT1 (0.55) SORT1SMN1; SMN2NPC1RAB9AMAPT
SCHEMBL15901600 0.83 SORT1 (0.78) SORT1GPR27SCN10AHDAC4HDAC6
SCHEMBL15901610 0.82 KMT2A (0.54) SORT1ALDH1A1SMN1; SMN2KMT2AGAA
SCHEMBL15902053 0.81 SORT1 (0.65) SORT1SCN10AKCNK3KCNK9HDAC4
SCHEMBL15902067 0.81 SORT1 (0.55) SORT1SMN1; SMN2NPC1RAB9AMAPT
SCHEMBL15902028 0.80 SORT1 (0.57) SORT1SMN1; SMN2NPC1RAB9AMAPT
SCHEMBL15902152 0.79 SORT1 (0.56) SORT1ALDH1A1SMN1; SMN2KMT2ANPC1
SCHEMBL24669404 0.78 ALDH1A1 (0.60) ALDH1A1SMN1; SMN2KMT2ALMNAGAA
SCHEMBL27463945 0.78 KCNK3 (0.66) ALDH1A1SMN1; SMN2KMT2ALMNANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 40 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3459958-B1 PROCESS AND INTERMEDIATES FOR PREPARING PRODRUGS OF PYRIDONE AMIDES USEFUL AS MODULATORS OF SODIUM CHANNELS VERTEX PHARMA (US) 2024-08-07 EP disclosed
CN-114437062-B Compound capable of being used as sodium channel regulator and application thereof 成都海博为药业有限公司 2024-05-17 CN disclosed
US-11773119-B2 Prodrugs of pyridone amides useful as modulators of sodium channels VERTEX PHARMACEUTICALS INCORPORATED (US) 2023-10-03 US disclosed
US-11673864-B2 Pyridone amides as modulators of sodium channels VERTEX PHARMACEUTICALS INCORPORATED (US) 2023-06-13 US disclosed
CN-114437062-A Compound capable of being used as sodium channel regulator and application thereof 成都海博为药业有限公司 2022-05-06 CN disclosed
EP-3865475-A1 PROCESS FOR PREPARING PYRIDONE AMIDES WHICH ARE MODULATORS OF SODIUM CHANNELS AND INTERMEDIATE COMPOUNDS USED THEREIN Vertex Pharmaceuticals Incorporated (US) 2021-08-18 EP disclosed
CN-108395452-B Prodrugs of pyridone amides as sodium channel modulators 沃泰克斯药物股份有限公司 2021-08-03 CN disclosed
CN-108164457-B Pyridone amides as sodium channel modulators 沃泰克斯药物股份有限公司 2021-07-09 CN disclosed
US-20210047271-A1 PYRIDONE AMIDES AS MODULATORS OF SODIUM CHANNELS VERTEX PHARMACEUTICALS (SAN DIEGO) LLC 2021-02-18 US disclosed
EP-3239134-B1 PYRIDONE AMIDES AS MODULATORS OF SODIUM CHANNELS VERTEX PHARMA (US) 2020-12-23 EP disclosed
US-20160009743-A1 PRODRUGS OF PYRIDONE AMIDES USEFUL AS MODULATORS OF SODIUM CHANNELS VERTEX PHARMACEUTICALS (SAN DIEGO) LLC 2016-01-14 US disclosed
EP-2953931-A1 PYRIDONE AMIDES AS MODULATORS OF SODIUM CHANNELS Vertex Pharmaceuticals Incorporated (US) 2015-12-16 EP disclosed
US-9163042-B2 Prodrugs of pyridone amides useful as modulators of sodium channels VERTEX PHARMACEUTICALS INCORPORATED (US) 2015-10-20 US disclosed
US-20150246028-A1 PYRIDONE AMIDES AS MODULATORS OF SODIUM CHANNELS VERTEX PHARMACEUTICALS INCORPORATED 2015-09-03 US disclosed
WO-2015089361-A1 PRODRUGS OF PYRIDONE AMIDES USEFUL AS MODULATORS OF SODIUM CHANNELS VERTEX PHARMACEUTICALS INCORPORATED (US) 2015-06-18 WO disclosed
US-20150166589-A1 PRODRUGS OF PYRIDONE AMIDES USEFUL AS MODULATORS OF SODIUM CHANNELS VERTEX PHARMACEUTICALS (EUROPE) LIMITED (GB) 2015-06-18 US disclosed
US-9051270-B2 Pyridone amides as modulators of sodium channels VERTEX PHARMACEUTICALS INCORPORATED (US) 2015-06-09 US disclosed
WO-2014120808-A9 PYRIDONE AMIDES AS MODULATORS OF SODIUM CHANNELS VERTEX PARMACEUTICALS INCORPORATED (US) 2015-05-14 WO disclosed
WO-2014120808-A1 PYRIDONE AMIDES AS MODULATORS OF SODIUM CHANNELS VERTEX PARMACEUTICALS INCORPORATED (US) 2014-08-07 WO disclosed
US-20140213616-A1 PYRIDONE AMIDES AS MODULATORS OF SODIUM CHANNELS VERTEX PHARMACEUTICALS INCORPORATED (US) 2014-07-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150246028-A1 PYRIDONE AMIDES AS MODULATORS OF SODIUM CHANNELS SCN5A, SCN1A, KCNJ2 SORT1 4300/4885ALDH1A1 1133/4885SMN1; SMN2 472/4885
US-20160009743-A1 PRODRUGS OF PYRIDONE AMIDES USEFUL AS MODULATORS OF SODIUM CHANNELS TRPV1, P2RY1, P2RX3 SORT1 3691/4885ALDH1A1 886/4885SMN1; SMN2 604/4885
US-20140213616-A1 PYRIDONE AMIDES AS MODULATORS OF SODIUM CHANNELS SCN5A, SCN1A, KCNJ2 SORT1 4300/4885ALDH1A1 1133/4885SMN1; SMN2 472/4885
US-20150166589-A1 PRODRUGS OF PYRIDONE AMIDES USEFUL AS MODULATORS OF SODIUM CHANNELS TRPV1, P2RY1, P2RX3 SORT1 3691/4885ALDH1A1 886/4885SMN1; SMN2 604/4885
US-11773119-B2 Prodrugs of pyridone amides useful as modulators of sodium channels TRPV1, P2RY1, P2RX3 SORT1 3691/4885ALDH1A1 886/4885SMN1; SMN2 604/4885
US-20210047271-A1 PYRIDONE AMIDES AS MODULATORS OF SODIUM CHANNELS SCN5A, SCN1A, KCNJ2 SORT1 4300/4885ALDH1A1 1133/4885SMN1; SMN2 472/4885
US-11673864-B2 Pyridone amides as modulators of sodium channels SCN5A, SCN1A, KCNJ2 SORT1 4300/4885ALDH1A1 1133/4885SMN1; SMN2 472/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.